Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients.

Johansson SL, Wulf-Johansson H, Schlosser A, Titlestad IL, Miller B, Tal-Singer R, Holmskov U, Vestbo J, Sørensen GL.

ERJ Open Res. 2019 Apr 15;5(2). pii: 00021-2019. doi: 10.1183/23120541.00021-2019. eCollection 2019 Apr.

2.

Danish respiratory society position paper: palliative care in patients with chronic progressive non-malignant lung diseases.

Marsaa K, Gundestrup S, Jensen JU, Lange P, Løkke A, Roberts NB, Shaker SB, Sørensen AR, Titlestad IL, Thomsen LH, Weinreich UM, Bendstrup E, Wilcke T.

Eur Clin Respir J. 2018 Oct 16;5(1):1530029. doi: 10.1080/20018525.2018.1530029. eCollection 2018. Review.

3.

[Treatment limitations or discontinuation in patients with benign pulmonary diseases].

Sørensen AR, Bendstrup E, Løkke A, Titlestad IL, Jensen JU, Thomsen L, Roberts N, Gjørup P, Shaker S, Gundestrup S, Wilcke T, Weinreich UM, Marsaa K.

Ugeskr Laeger. 2018 Sep 24;180(39). pii: V04180270. Danish.

PMID:
30274574
4.

[Treatment of stable chronic obstructive pulmonary disease].

Løkke A, Nielsen LP, Moberg M, Marså K, Titlestad IL, Kofod LM, Godtfredsen NS.

Ugeskr Laeger. 2018 Jun 18;180(25). pii: V11170855. Danish.

PMID:
29938633
5.

Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trial.

Russell RJ, Chachi L, FitzGerald JM, Backer V, Olivenstein R, Titlestad IL, Ulrik CS, Harrison T, Singh D, Chaudhuri R, Leaker B, McGarvey L, Siddiqui S, Wang M, Braddock M, Nordenmark LH, Cohen D, Parikh H, Colice G, Brightling CE; MESOS study investigators.

Lancet Respir Med. 2018 Jul;6(7):499-510. doi: 10.1016/S2213-2600(18)30201-7. Epub 2018 May 21.

PMID:
29793857
6.

Surgical treatment versus conventional chest tube drainage in primary spontaneous pneumothorax: a randomized controlled trial.

Olesen WH, Katballe N, Sindby JE, Titlestad IL, Andersen PE, Lindahl-Jacobsen R, Licht PB.

Eur J Cardiothorac Surg. 2018 Jul 1;54(1):113-121. doi: 10.1093/ejcts/ezy003.

PMID:
29509892
7.

Development of non-invasive ventilation treatment practice for patients with chronic obstructive pulmonary disease:Results from a participatory research project.

Christensen HM, Titlestad IL, Huniche L.

SAGE Open Med. 2017 Nov 10;5:2050312117739785. doi: 10.1177/2050312117739785. eCollection 2017.

8.

A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations - The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol.

Sivapalan P, Moberg M, Eklöf J, Janner J, Vestbo J, Laub RR, Browatzki A, Armbruster K, Wilcke JT, Seersholm N, Weinreich UM, Titlestad IL, Andreassen HF, Ulrik CS, Bødtger U, Nielsen TL, Hansen EF, Jensen JUS.

BMC Pulm Med. 2017 Aug 15;17(1):114. doi: 10.1186/s12890-017-0458-7.

9.

Cannabis increased the risk of primary spontaneous pneumothorax in tobacco smokers: a case-control study.

Hedevang Olesen W, Katballe N, Sindby JE, Titlestad IL, Andersen PE, Ekholm O, Lindahl-Jacobsen R, Licht PB.

Eur J Cardiothorac Surg. 2017 Oct 1;52(4):679-685. doi: 10.1093/ejcts/ezx160.

PMID:
28605480
10.

Involvement of patients' perspectives on treatment with noninvasive ventilation in patients with chronic obstructive pulmonary disease-A qualitative study.

Christensen HM, Huniche L, Titlestad IL.

J Clin Nurs. 2018 Jan;27(1-2):e61-e69. doi: 10.1111/jocn.13847. Epub 2017 Jul 5.

PMID:
28401600
11.

Undiagnosed chronic obstructive pulmonary disease in patients admitted to an acute assessment unit.

Eikhof KD, Olsen KR, Wrengler NC, Nielsen C, Bodtger U, Titlestad IL, Weinreich UM.

Eur Clin Respir J. 2017 Mar 8;4(1):1292376. doi: 10.1080/20018525.2017.1292376. eCollection 2017.

12.

Recurrent Primary Spontaneous Pneumothorax is Common Following Chest Tube and Conservative Treatment.

Olesen WH, Lindahl-Jacobsen R, Katballe N, Sindby JE, Titlestad IL, Andersen PE, Licht PB.

World J Surg. 2016 Sep;40(9):2163-70. doi: 10.1007/s00268-016-3508-z.

PMID:
27091206
13.

Early telemedicine training and counselling after hospitalization in patients with severe chronic obstructive pulmonary disease: a feasibility study.

Rosenbek Minet L, Hansen LW, Pedersen CD, Titlestad IL, Christensen JK, Kidholm K, Rayce K, Bowes A, Møllegård L.

BMC Med Inform Decis Mak. 2015 Feb 7;15:3. doi: 10.1186/s12911-014-0124-4.

14.
15.

[Bronchoscopic lung volume reduction is a treatment offered to patients with severe heterogenous emphysema].

Perch M, Titlestad IL, Rychwicha-Kielek BA, Bendstrup E, Iversen M, Siemsen M, Jørgensen OD, Haahr PE.

Ugeskr Laeger. 2014 Jul 14;176(29):V01140005. Review. Danish.

PMID:
25292200
16.

Microfibrillar-associated protein 4: a potential biomarker of chronic obstructive pulmonary disease.

Johansson SL, Roberts NB, Schlosser A, Andersen CB, Carlsen J, Wulf-Johansson H, Sækmose SG, Titlestad IL, Tornoe I, Miller B, Tal-Singer R, Holmskov U, Vestbo J, Sorensen GL.

Respir Med. 2014 Sep;108(9):1336-44. doi: 10.1016/j.rmed.2014.06.003. Epub 2014 Jun 20.

17.

Surfactant protein D is a candidate biomarker for subclinical tobacco smoke-induced lung damage.

Johansson SL, Tan Q, Holst R, Christiansen L, Hansen NC, Hojland AT, Wulf-Johansson H, Schlosser A, Titlestad IL, Vestbo J, Holmskov U, Kyvik KO, Sorensen GL.

Am J Physiol Lung Cell Mol Physiol. 2014 May 1;306(9):L887-95. doi: 10.1152/ajplung.00340.2013. Epub 2014 Mar 7.

18.

Plasma YKL-40 and all-cause mortality in patients with chronic obstructive pulmonary disease.

Holmgaard DB, Mygind LH, Titlestad IL, Madsen H, Pedersen SS, Johansen JS, Pedersen C.

BMC Pulm Med. 2013 Dec 30;13:77. doi: 10.1186/1471-2466-13-77.

19.

Are patients with COPD treated with NIV in accordance with national guidelines? An internal audit.

Titlestad IL, Olsen F, Sandqvist HM, Pourbazargan MM, Fretheim HH, Lassen AT, Vestbo J.

Eur Clin Respir J. 2014 Nov 11;1. doi: 10.3402/ecrj.v1.24506. eCollection 2014.

20.

The effect of real-time teleconsultations between hospital-based nurses and patients with severe COPD discharged after an exacerbation.

Sorknaes AD, Bech M, Madsen H, Titlestad IL, Hounsgaard L, Hansen-Nord M, Jest P, Olesen F, Lauridsen J, Østergaard B.

J Telemed Telecare. 2013 Dec;19(8):466-74. doi: 10.1177/1357633X13512067. Epub 2013 Nov 13.

PMID:
24227799
21.

Authors’ reply.

Titlestad IL, Lassen AT, Vestbo J.

Int J Chron Obstruct Pulmon Dis. 2013;8:381. No abstract available.

PMID:
24137821
22.

[Medical treatment of COPD].

Vestbo J, Titlestad IL.

Ugeskr Laeger. 2013 Apr 29;175(18):1261-4. Review. Danish.

PMID:
23651802
23.

Long-term survival for COPD patients receiving noninvasive ventilation for acute respiratory failure.

Titlestad IL, Lassen AT, Vestbo J.

Int J Chron Obstruct Pulmon Dis. 2013;8:215-9. doi: 10.2147/COPD.S42632. Epub 2013 Apr 26.

24.

Serum vitamin D in patients with chronic obstructive lung disease does not correlate with mortality--results from a 10-year prospective cohort study.

Holmgaard DB, Mygind LH, Titlestad IL, Madsen H, Fruekilde PB, Pedersen SS, Pedersen C.

PLoS One. 2013;8(1):e53670. doi: 10.1371/journal.pone.0053670. Epub 2013 Jan 14.

25.
26.

HLA haplotypes in dizygotic twin pairs: are dizygotic twins more similar than sibs?

Titlestad IL, Kyvik KO, Kristensen T, Lillevang S.

Twin Res. 2002 Aug;5(4):287-8.

PMID:
12217235
27.

Hepatitis B core antibodies in Danish blood donors: a surrogate marker of risk behaviour.

Christensen PB, Titlestad IL, Homburg KM, Georgsen J, Kristensen T.

Vox Sang. 2001 Nov;81(4):222-7.

PMID:
11903997
28.

Leukocyte-depletion of blood components does not significantly reduce the risk of infectious complications. Results of a double-blinded, randomized study.

Titlestad IL, Ebbesen LS, Ainsworth AP, Lillevang ST, Qvist N, Georgsen J.

Int J Colorectal Dis. 2001 Jun;16(3):147-53.

PMID:
11459288
29.

Pilot scale purification of human monoclonal IgM (COU-1) for clinical trials.

Tornøe I, Titlestad IL, Kejling K, Erb K, Ditzel HJ, Jensenius JC.

J Immunol Methods. 1997 Jun 23;205(1):11-7.

PMID:
9236910

Supplemental Content

Loading ...
Support Center